DARPP-32 increases interactions between epidermal growth factor receptor and ERBB3 to promote tumor resistance to gefitinib.
about
DARPP-32: from neurotransmission to cancerHigh Expression of DARPP-32 in Colorectal Cancer Is Associated With Liver Metastases and Predicts Survival for Dukes A and B Patients: Results of a Pilot Study.Regulation of CD44E by DARPP-32-dependent activation of SRp20 splicing factor in gastric tumorigenesis.Gastric tumour-derived ANGPT2 regulation by DARPP-32 promotes angiogenesisPreclinical modeling of EGFR inhibitor resistance in head and neck cancer.Regulation of CXCR4-mediated invasion by DARPP-32 in gastric cancer cellsIsoprenaline Induces Periostin Expression in Gastric Cancer.APIP, an ERBB3-binding partner, stimulates erbB2-3 heterodimer formation to promote tumorigenesis.Helicobacter pylori-induced cell death is counteracted by NF-κB-mediated transcription of DARPP-32The role of epidermal growth factor receptor in prognosis and treatment of gastric cancer.Integrated expression analysis identifies transcription networks in mouse and human gastric neoplasia.Activation of EIF4E by Aurora Kinase A Depicts a Novel Druggable Axis in Everolimus-Resistant Cancer Cells.PPP1R1B-STARD3 chimeric fusion transcript in human gastric cancer promotes tumorigenesis through activation of PI3K/AKT signaling.3D pancreatic carcinoma spheroids induce a matrix-rich, chemoresistant phenotype offering a better model for drug testing.The evolutionary strata of DARPP-32 tail implicates hierarchical functional expansion in higher vertebrates.Evaluation of Protein Levels of the Receptor Tyrosine Kinase ErbB3 in Serum.DARPP-32 and t-DARPP promote non-small cell lung cancer growth through regulation of IKKα-dependent cell migration
P2860
Q26766237-44EA6B5F-D343-4080-AF56-E5FCE53676B9Q35110657-70A27A78-9859-48F0-90FF-4245A2C6830CQ35801261-419F310B-F55A-4053-98C1-8DCEF4E157C2Q36069142-D0379466-6066-4D67-B37A-0E9017091EB0Q36149312-A80A5FB1-1DF0-470A-B9A3-A7C9646E0C67Q36553388-E3A28B45-7BF3-4600-A6FF-8F85F1CC72ABQ36707860-3E685F0C-3E95-430C-A25B-CCA9C1202C93Q37225352-AC7A9EE6-BB66-4517-AD11-CAA771438D0DQ37678094-FA842CC0-68B3-456F-9F46-104CA46791BDQ38177325-45A0A68F-3FD7-4CB7-B624-092F24E09DD7Q38915431-5068870C-20DF-4777-A9AD-43772FAE48B5Q39028389-3684FD1D-EF29-4A62-A6E4-F1C85179C2BFQ39054981-B4C1F6CE-1A21-47D5-B429-472EF99C60E4Q39187713-A72A3854-66DE-4CBA-AEC2-06201774C3C7Q39189145-E5BC7C1F-803E-4057-AA6F-0E312539BF48Q46942173-2C360A40-BAD6-46B3-93C7-F72751C7D498Q56815794-FB5D19BC-F3F0-4F92-9C0B-F7EC3264FC01
P2860
DARPP-32 increases interactions between epidermal growth factor receptor and ERBB3 to promote tumor resistance to gefitinib.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
DARPP-32 increases interaction ...... tumor resistance to gefitinib.
@ast
DARPP-32 increases interaction ...... tumor resistance to gefitinib.
@en
type
label
DARPP-32 increases interaction ...... tumor resistance to gefitinib.
@ast
DARPP-32 increases interaction ...... tumor resistance to gefitinib.
@en
prefLabel
DARPP-32 increases interaction ...... tumor resistance to gefitinib.
@ast
DARPP-32 increases interaction ...... tumor resistance to gefitinib.
@en
P2093
P2860
P1433
P1476
DARPP-32 increases interaction ...... tumor resistance to gefitinib.
@en
P2093
Abbes Belkhiri
Shoumin Zhu
Wael El-Rifai
P2860
P304
1738-48.e1-2
P356
10.1053/J.GASTRO.2011.06.070
P407
P577
2011-07-07T00:00:00Z